Hu, X., Ouyang, W., Chen, H., Liu, Z., Lai, Z., & Yao, H. (2025). Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity. Cancer Pathogenesis and Therapy, 3(3), 253. https://doi.org/10.1016/j.cpt.2024.09.006
Chicago-referens (17:e uppl.)Hu, Xingbin, Wenhao Ouyang, Haizhu Chen, Zhihong Liu, Zijia Lai, och Herui Yao. "Claudin-9 (CLDN9) Promotes Gastric Cancer Progression by Enhancing the Glycolysis Pathway and Facilitating PD-L1 Lactylation to Suppress CD8+ T Cell Anti-tumor Immunity." Cancer Pathogenesis and Therapy 3, no. 3 (2025): 253. https://doi.org/10.1016/j.cpt.2024.09.006.
MLA-referens (9:e uppl.)Hu, Xingbin, et al. "Claudin-9 (CLDN9) Promotes Gastric Cancer Progression by Enhancing the Glycolysis Pathway and Facilitating PD-L1 Lactylation to Suppress CD8+ T Cell Anti-tumor Immunity." Cancer Pathogenesis and Therapy, vol. 3, no. 3, 2025, p. 253, https://doi.org/10.1016/j.cpt.2024.09.006.
